← Back
Data updated: Mar 10, 2026
SHREE HARI INTL
NeurologyImmunology
SHREE HARI INTL is a generic drug manufacturer focused on Neurology, Immunology.
1985
Since
4
Drugs
-
Trials
63
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
BETAMETHASONE DIPROPIONATE 2026-01-26
AMANTADINE HYDROCHLORIDE 2025-12-05
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
AMANTADINE HYDROCHLORIDE 2025-07-10
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 50%
1 drugs
Immunology 50%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (1)
Company Info
- First Approval
- 1985-08-12
- Latest
- 2025-12-05
- Applications
- 4